No headlines found.
Globe Newswire (Fri, 30-Jan 8:00 AM ET)
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
Globe Newswire (Thu, 8-Jan 8:00 AM ET)
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Alps Group - Ordinary Share trades on the NASDAQ stock market under the symbol ALPS.
As of February 18, 2026, ALPS stock price climbed to $0.90 with 4,480 million shares trading.
ALPS has a beta of 9.48, meaning it tends to be more sensitive to market movements. ALPS has a correlation of 0.13 to the broad based SPY ETF.
ALPS has a market cap of $150.59 million. This is considered a Micro Cap stock.
ALPS support price is $.85 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALPS shares will trade within this expected range on the day.
